Trial intelligence / Profile preview

Anti-TNFα Suspension vs Continuation in RA Foot/Ankle Surgery

NCT02242474Phase 4Unknown

Sponsor
CHU de Québec-Université Laval
Start
Jul 2015
Primary completion
Oct 2019
Countries
1
01

Overview

Phase 4, randomised, open-label trial in rheumatoid arthritis (RA) (2 arms), sponsored by CHU de Québec-Université Laval. Primary endpoint: Surgical site infection at 1 year. Status: unknown.

02

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT02242474.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02242474.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call